|
Hb change range (g/L)
|
Quartile 1:
|
Quartile 2:
|
Quartile 3:
|
Quartile 4:
|
p-value
|
|---|
|
−45 – –10 (n = 58)
|
−9 – −2 (n = 55)
|
−1 – +6 (n = 56)
|
+7 – +28 (n = 51)
|
(comparing q1 with q4)
|
|---|
|
Hb at baseline in men (g/L) mean ± SD
|
134.3 ± 11.0 (n = 22)
|
132.6 ± 9.9 (n = 16)
|
127.7 ± 14.0 (n = 15)
|
112.9 ± 11.3 (n = 12)
|
p < 0.001
|
|
Hb at baseline in women (g/L) mean ± SD
|
128.2 ± 10.8 (n = 36)
|
127.0 ± 13.0 (n = 39)
|
123.4 ± 10.9 (n = 41)
|
120.5 ± 13.1 (n = 39)
|
p = 0.007
|
|
Male sex (%)
|
37.9 (n = 22)
|
29.1 (n = 16)
|
26.8 (n = 15)
|
23.5 (n = 12)
|
P = 0.10
|
|
Age (years)
|
83.4 ± 8.3 (n = 58)
|
83.6 ± 6.3 (n = 55)
|
83.1 ± 7.3 (n = 56)
|
85.7 ± 5.8 (n = 51)
|
p = 0.10
|
|
Number of drugs, mean ± SD
|
7.2 ± 3.0 (n = 58)
|
6.7 ± 2.5 (n = 55)
|
6.8 ± 3.1 (n = 56)
|
6.7 ± 3.5 (n = 51)
|
p = 0.47
|
|
BMI (kg/m2) mean ± SD
|
25.5 (±5.1) (n = 58)
|
25.6 ± 5.0 (n = 55)
|
25.0 ± 4.4 (n = 56)
|
24.9 (±4.8) (n = 51)
|
p = 0.53
|
|
eGFR (mL/min)
|
56.8 ± 16.1 (n = 58)
|
55.7 ± 14.3 (n = 55)
|
51.9 ± 14.4 (n = 56)
|
54.2 ± 15.7 (n = 51)
|
p = 0.38
|
|
BNP (ng/L) mean ± SD
|
139.4 ± 190.2 (n = 57)
|
117.8 ± 166.4 (n = 54)
|
159.6 ± 235.8 (n = 55)
|
128.6 ± 114.0 (n = 51)
|
p = 0.72
|
|
MNA-SF initial result mean ± SD
|
10.5 ± 2.3 (n = 58)
|
10.9 ± 2.2 (n = 55)
|
10.8 ± 2.1 (n = 55)
|
10.4 ± 2.8 (n = 51)
|
p = 0.74
|
|
MMSE result mean ± SD
|
16.2 ± 6.7 (n = 49)
|
17.6 ± 6.0 (n = 50)
|
17.8 ± 6.5 (n = 49)
|
17.9 ± 6.2 (n = 49)
|
p = 0.20
|
|
1 year mortality (%)
|
36.2
|
18.2
|
17.9
|
17.6
| |
|
p = 0.032 (q1 vs q2)
|
p = 0.028 (q1 vs q3)
|
P = 0.030 (q1 vs q4)
|
- Hb hemoglobin, q quartile, SD standard deviation, BMI Body Mass Index, BNP B-type natriuretic peptide, eGFR estimated glomerular filtration rate, MNA-SF Short-form Mini-nutritional assessment, MMSE Mini Mental State Examination
